A Double-Blind, Placebo-Controlled Trial of Clonazepam in Obsessive-Compulsive Disorder

References

• Ackerman D L, Greenland S. Multivariate Meta-Analysis of Controlled Drug Studies for Obsessive-Compulsive Disorder. J Clin Psychopharmacol 2002; 22: 309–317
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: 4^th ed. American Psychiatric Association, Washington, DC 1995
   Google Scholar
• Bacher N H. Clonazepam Treatment of Obsessive Compulsive Disorder. J Clin Psychiatry 1990; 51(4)168–169
   PubMedGoogle Scholar
• Bodkin J A, White K. Clonazepam in the treatment of Obsessive Compulsive Disorder associated with Panic Disorder in one patient. J Clin Psychiatry 1989; 50: 265–266
   PubMedGoogle Scholar
• Cartwright C, Hollander E. SSRIs in the treatment of OCD. Depression and Anxiety 1998; 8((1))105–-113
   PubMedGoogle Scholar
• Chadwick D, Jenner P, Harris R, Reynolds E H, Marsden C D. Manipulation of brain serotonin in the treatment of myoclonus. Lancet 1975; 2: 434–435
   PubMedGoogle Scholar
• Chadwick D, Hallett M, Harris R, Jenner P, Reynolds E H, Marsden C D. Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam. Brain 1977; 100((3))455–-487
   PubMedGoogle Scholar
• Clomipramine Collaborative Study Croup (CCSG). Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1991; 48((8))730–-738
   PubMedGoogle Scholar
• Davidson J R, Moroz G. Pivotal studies of clonazepam in Panic Disorder. Psychopharmacol Bull 1998; 34((2))169–-174
   PubMedGoogle Scholar
• Davidson J R, Potts N S, Richichi E, Krishnar R, Ford S M, Smith R, Wilson W H. Treatment of social phobia with clonazepam and Placebo. J Clin Psychopharmacol 1993; 13: 423–428
   PubMed Web of Science ®Google Scholar
• Hewlett W A, Vinogradov S, Agras W S. Clonazepam treatment of obsessions and compulsions. J Clin Psychiatry 1990; 51: 158–161
   PubMedGoogle Scholar
• Hewlett W A, Vinogradov S, Agras W S. Clomipramine, clonazepam, and clonidine treatment of Obsessive-Compulsive Disorder. J Clin Psychopharmacol 1992; 12: 420–430
   PubMed Web of Science ®Google Scholar
• Hwang E C, Van Woert M H. Antimyoclonic action of clonazepam: the role of serotonin. Eur J Pharmacology 1979; 60: 31–40
   PubMedGoogle Scholar
• Karno M, Golding J M, Sorenson S B, Burnam M A. The epidemiology of Obsessive-Compulsive Disorder in five US communities. Arch Gen Psychiatry 1988; 45: 1094–1099
   PubMed Web of Science ®Google Scholar
• Leonard H L, Topol D, Bukstein O, Hindmarsh D, Allen A J, Swedo S E. Clonazepam as an augmenting agent in the treatment of childhood-onset Obsessive-Compulsive Disorder. J Am Acad Child Adolesc Psychiatry 1994; 33: 792–794
   PubMed Web of Science ®Google Scholar
• Montgomery S A, McIntyre A, Osterheider M, Sareschi P, Zitterl W, Zohar J, Birkett M, Wood A J. A double blind, placebo-controlled study of fluoxetine in patients with DSM-III-R Obsessive-Compulsive Disorder. Lilly European OCD Study Group. Eur Neuropyshopharmacol 1993; 3: 143–152
   PubMedGoogle Scholar
• Pigott T A, L'Heureux F, Rubenstein C S. Clonazepam augmentation in OCD patients treated with clomipramine or fluoxetine. New Research Program and Abstracts of the 145th Annual Meeting of the American Psychiatric Association. Washington, DC 1992; 82, Abstract NR144
   Google Scholar
• Pratt J, Jenner P, Reynolds E H, Marsden C D. Clonazepam induces decreased serotonergic activity in the mouse brain. Neuropharmacology 1979; 18: 791–799
   PubMedGoogle Scholar
• Ross D C, Piggott L R. Clonazepam for OCD (letter). J Am Acad Child Adoles Psychiatry 1993; 32: 470
   PubMedGoogle Scholar
• Stein D J, Hollander E, Mullen L S, DeCaria C M, Liebowitz M R. Comparison of clomipramine, alprazolam and placebo in the treatment of Obsessive-Compulsive Disorder. Human Psychopharmacology 1992; 7: 389–395
   Web of Science ®Google Scholar
• Wagner H R, Reches A, Yablonskaya E, Fahn S. Clonazepam-induced up-regulation of serotonin-1 and serotonin-2 binding sites in rat frontal cortex. Adv Neurol 1986; 43: 645–651
   PubMedGoogle Scholar
• Weissman M M, Bland R C, Canino G J, Greenwald S, Hwu H, Lee C K, Newman S C, Oakley-Browne M A, Rubio-Stipec M, Wickramaratne P J, Wittchen H, Yeh E. The cross national epidemiology of Obsessive-Compulsive Disorder. The Cross National Collaborative Group. J Clin Psychiatry 1994; 55(March Suppl)5–10
   PubMedGoogle Scholar